Tamoxifen maculopathy.
D000230:Adenocarcinoma / Q000517:prevention & control / Q000601:surgery; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000517:prevention & control / Q000601:surgery; D005260:Female; D006801:Humans; D008266:Macula Lutea / Q000187:drug effects*; D008875:Middle Aged; D012164:Retinal Diseases / Q000139:chemically induced*; D055502:Secondary Prevention; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen